EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY-NC-ND 4.0

Long‐term survival outcomes in young‐onset colorectal cancer: A population‐based cohort study

Amy M Y Cao iD, Michael L R Lonne iD, David A Clark iD

Colorectal Disease · 2025

DOI: 10.1111/codi.70007 ↗

At a glance

Kohortenstudie in Colorectal Disease, 2025. Written by Amy M Y Cao and 2 co-authors. Institution: Department of Colorectal Surgery, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia. Major MEDLINE topics: Colorectal Neoplasms. Cited 7 times so far (Crossref); 17 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aim

Long‐term survival outcomes in young‐onset colorectal cancer patients are contradictory and inconsistent. Some studies report overall survival to be significantly superior compared with older adults, while others report worse survival. Worldwide, the incidence of young‐onset colorectal cancer has, alarmingly, nearly doubled since the 1990s, in stark contrast to that in those over 50 years of age. Long‐term survival in young‐onset colorectal cancer has not been explored in the Australian population. The aim of this study was to investigate cancer‐specific and overall survival up to 10 years.

Method

This was a retrospective population‐based cohort study. All colorectal cancer diagnoses between 2001 and 2020 in the state of Queensland, Australia were reviewed. Young‐onset colorectal cancer (20–49 years) was compared with late‐onset colorectal cancer (50 years+).

Results

There were 52 697 adults diagnosed with colorectal cancer in Queensland. Young‐onset colorectal cancer accounted for 7.7% of these. Young‐onset colorectal cancer had a greater proportion of Stage III and IV disease than the late‐onset group (66% vs. 59%, p < 0.001). Despite this, young‐onset colorectal cancer had statistically significant improved overall survival at all time points to 10 years ( p < 0.001). Stage‐for‐stage cancer‐specific survival to 10 years was superior in all stages in young‐onset colorectal cancer ( p < 0.001).

Conclusion

Both stage‐for‐stage cancer‐specific and overall survival were superior in young‐onset colorectal cancer compared with those aged 50 years and above, up to 10 years.

Subjects

MeSH terms (MEDLINE)

Colorectal NeoplasmsHumansAge of OnsetRetrospective StudiesFemaleMiddle AgedAdultQueenslandMaleNeoplasm StagingYoung AdultSurvival RateAge FactorsCohort StudiesTime FactorsIncidenceSurvival Analysis

Author keywords

long termsurvivalyoung‐onset colorectal cancer

Authors and institutions

  • Department of Colorectal Surgery, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • Department of Colorectal Surgery, Westmead Hospital, Westmead, New South Wales, Australia.
  • Faculty of Medicine, University of Queensland, Herston, Queensland, Australia.

ORCID profiles: Amy M Y Cao, Michael L R Lonne, David A Clark

Cite

APA

Cao, A. M. Y., Lonne, M. L. R., & Clark, D. A. (2025). Long‐term survival outcomes in young‐onset colorectal cancer: A population‐based cohort study. Colorectal Disease. https://doi.org/10.1111/codi.70007

Vancouver

Cao AMY, Lonne MLR, Clark DA. Long‐term survival outcomes in young‐onset colorectal cancer: A population‐based cohort study. Colorectal Disease. 2025. doi:10.1111/codi.70007

BibTeX
@article{Cao2025,
  author = {Cao, Amy M Y and Lonne, Michael L R and Clark, David A},
  title = {Long‐term survival outcomes in young‐onset colorectal cancer: A population‐based cohort study},
  journal = {Colorectal Disease},
  year = {2025},
  doi = {10.1111/codi.70007}
}
Start for free →